Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes

Autor: Cédric Lemogne, B. Bonin, P. Callier, S. Ragot, A.-L. Mosca-Boidron, Guido Bondolfi, Jean-Michel Petit, C. Allard, I. Simoneau, Eddy Ponavoy, J.-C. Chauvet-Gelinier, A. Rebaï, Bruno Vergès, Benjamin Bouillet, D. Callegarin, Benoit Trojak, N. Forestier

Publikováno v: Diabetes & Metabolism, Vol. 45, No 6 (2019) pp. 582-585
Journal of Diabetes & Metabolism
Journal of Diabetes & Metabolism, In press, ⟨10.1016/j.diabet.2018.11.005⟩

International audience; AimType A personality has been associated with increased survival in people with type 1 diabetes (T1D). Systemic low-grade inflammation may play a critical role, as suggested in recent reports, although the links between the i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e380278302fec16e8006ec9bd99a417a
https://pubmed.ncbi.nlm.nih.gov/30476653

Electrically-induced muscle fatigue affects feedforward mechanisms of control

Autor: N. Forestier, F. Monjo

Publikováno v: Clinical Neurophysiology
Clinical Neurophysiology, Elsevier, 2015, 126 (8), pp.1607-1616. 〈10.1016/j.clinph.2014.10.218〉
Clinical Neurophysiology, Elsevier, 2015, 126 (8), pp.1607-1616. ⟨10.1016/j.clinph.2014.10.218⟩

Objective To investigate the effects of focal muscle fatigue induced by electromyostimulation (EMS) on Anticipatory Postural Adjustments (APAs) during arm flexions performed at maximal velocity. Methods Fifteen healthy subjects performed self-paced a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df6fac5ac8a6b07cea05ebb4001c18bd
https://doi.org/10.1016/j.clinph.2014.10.218

Deutliche Verbesserungen der Patient-reported outcomes (PRO) können in Patienten mit chronischer Hepatitis C mit oder ohne Zirrhose beobachtet werden, die mit Sofosbuvir und Velpatasvir (SOF/VEL) behandelt werden: Ergebnisse aus ASTRAL-1, -2, -3 und -4

Autor: K Hüging, T.M. Welzel, M Gündogdu, N Forestier, S. Zeuzem, Peter Buggisch, Jörg Petersen

Publikováno v: Zeitschrift für Gastroenterologie. 54

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::739129e0494b5b783407fce28715f5c1
https://doi.org/10.1055/s-0036-1587002